Ardent Health Inc.
ARDT | NYSE
$10.61
+$0.13 (+1.24%)
At close: Sep 21, 2026, 4:00 PM ET
$10.80
+$0.19 (+1.79%)
Pre-market:
Sep 22, 2026, 9:16 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 724.48M | 609.69M | 709.6M | 609.44M | 540.63M | 495.04M | 556.79M | 563.14M | 334.54M | 372.77M | 437.58M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 2K | n/a | n/a | n/a | n/a | 1.36M | 11.46M | 3.31M | 7.88M | 18.67M | 17.8M |
Other Long-Term Assets | 123.66M | 116.27M | 111.69M | 111.59M | 111.19M | 115.55M | 131.51M | 134M | 136.62M | 125.94M | 129.31M |
Receivables | 695.95M | 709.19M | 686.1M | 729.41M | 821.64M | 776.52M | 743.03M | 744.95M | 720.99M | 722.68M | 785.76M |
Inventory | 116.02M | 119.84M | 118.59M | 121.59M | 118.4M | 120.36M | 115.09M | 108.23M | 105.01M | 106M | 105.49M |
Other Current Assets | 370.53M | 414.94M | 544.53M | 366.13M | 268.56M | 238.97M | 304.09M | 154.42M | 205.22M | 191.38M | 211.99M |
Total Current Assets | 2.05B | 2.02B | 2.06B | 1.96B | 1.88B | 1.76B | 1.83B | 1.69B | 1.5B | 1.49B | 1.62B |
Property-Plant & Equipment | 2.03B | 2.14B | 2.14B | 2.1B | 2.07B | 2.06B | 2.04B | 2.01B | 2B | 2B | 2.01B |
Goodwill & Intangibles | 966.94M | 967.6M | 968.79M | 967.6M | 954.61M | 953.52M | 929.01M | 928.93M | 928.93M | 929.05M | 921.63M |
Total Long-Term Assets | 3.13B | 3.23B | 3.23B | 3.2B | 3.15B | 3.15B | 3.12B | 3.11B | 3.11B | 3.1B | 3.48B |
Total Assets | 5.28B | 5.25B | 5.29B | 5.15B | 5.03B | 4.91B | 4.96B | 4.8B | 4.61B | 4.59B | 5.1B |
Account Payables | 429.77M | 419.72M | 457.94M | 381.85M | 364.45M | 371.92M | 401.25M | 368.85M | 371.1M | 383.09M | 474.54M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 28.57M | 37.64M | 23.44M | 19.34M | 19.33M | 17.76M | 9.23M | 12.17M | 10.73M | 16.65M | 61.03M |
Other Current Liabilities | n/a | 263.46M | 565.16M | 266.35M | 237.93M | 226.3M | 44.66M | 250.95M | 278.38M | 216.43M | 172.83M |
Total Current Liabilities | 976.32M | 951.48M | 1.05B | 943.15M | 880.87M | 830.14M | 945.42M | 887.33M | 908.56M | 834.78M | 994.1M |
Long-Term Debt | 1.07B | 1.07B | 1.08B | 1.09B | 1.09B | 1.09B | 1.07B | 1.08B | 1.08B | 1.17B | 1.15B |
Other Long-Term Liabilities | 324.6M | 322.04M | 317.69M | 323.12M | 252.66M | 258.14M | 261.75M | 285.64M | 299.55M | 315.44M | 319.55M |
Total Long-Term Liabilities | 2.56B | 2.57B | 2.56B | 2.58B | 2.5B | 2.52B | 2.49B | 2.53B | 2.54B | 2.64B | 3.03B |
Total Liabilities | 3.54B | 3.52B | 3.61B | 3.52B | 3.38B | 3.35B | 3.43B | 3.41B | 3.45B | 3.48B | 4.02B |
Total Debt | 2.27B | 2.29B | 2.26B | 2.28B | 2.27B | 2.28B | 2.28B | 2.25B | 2.25B | 2.34B | 2.4B |
Book Value | 1.74B | 1.73B | 1.68B | 1.63B | 1.65B | 1.56B | 1.52B | 1.39B | 1.16B | 1.12B | 1.08B |
Book Value Per Share | 12.17 | 12.21 | 11.91 | 11.55 | 11.67 | 11.12 | 11.47 | 10.08 | 8.14 | 7.78 | 7.62 |
Common Stock | 1.42M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M | 497.62M | 497.39M | 496.88M |
Retained Earnings | 558.36M | 541.46M | 501.61M | 456.65M | 480.13M | 407.18M | 365.8M | 251.59M | 225.27M | 182.5M | 155.45M |
Comprehensive Income | -638K | -2.45M | -3.61M | -2.63M | -396K | 3.93M | 9.74M | 9.49M | 17.01M | 19.26M | 18.56M |
Shareholders Equity | 1.35B | 1.73B | 1.69B | 1.24B | 1.25B | 1.18B | 1.13B | 1.01B | 739.9M | 699.16M | 670.9M |
Total Investments | 2K | n/a | n/a | n/a | n/a | 1.36M | 11.46M | 3.31M | 7.88M | 18.67M | 17.8M |
Add to Watchlist
Select watchlists to add or remove ARDT